Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 292

1.

Exposure to American Football and Neuropsychiatric Health in Former National Football League Players: Findings From the Football Players Health Study.

Roberts AL, Pascual-Leone A, Speizer FE, Zafonte RD, Baggish AL, Taylor H Jr, Nadler LM, Connor A, Grashow R, Stillman AM, Marengi DA, Weisskopf MG, Courtney TK.

Am J Sports Med. 2019 Aug 30:363546519868989. doi: 10.1177/0363546519868989. [Epub ahead of print]

PMID:
31468987
2.

Association of Concussion Symptoms With Testosterone Levels and Erectile Dysfunction in Former Professional US-Style Football Players.

Grashow R, Weisskopf MG, Miller KK, Nathan DM, Zafonte R, Speizer FE, Courtney TK, Baggish A, Taylor HA, Pascual-Leone A, Nadler LM, Roberts AL.

JAMA Neurol. 2019 Aug 26. doi: 10.1001/jamaneurol.2019.2664. [Epub ahead of print]

3.

The Football Players' Health Study at Harvard University: Design and objectives.

Zafonte R, Pascual-Leone A, Baggish A, Weisskopf MG, Taylor HA, Connor A, Baker J, Cohan S, Valdivia C, Courtney TK, Cohen IG, Speizer FE, Nadler LM.

Am J Ind Med. 2019 Aug;62(8):643-654. doi: 10.1002/ajim.22991. Epub 2019 Jun 18.

PMID:
31210374
4.

Multisystem afflictions in former National Football League players.

Morris TP, McCracken C, Baggish A, Weisskopf M, Zafonte R, Taylor HA, Nadler LM, Speizer FE, Pascual-Leone A.

Am J Ind Med. 2019 Aug;62(8):655-662. doi: 10.1002/ajim.22992. Epub 2019 May 27.

5.

Mortality Among Professional American-Style Football Players and Professional American Baseball Players.

Nguyen VT, Zafonte RD, Chen JT, Kponee-Shovein KZ, Paganoni S, Pascual-Leone A, Speizer FE, Baggish AL, Taylor HA Jr, Nadler LM, Courtney TK, Connor A, Weisskopf MG.

JAMA Netw Open. 2019 May 3;2(5):e194223. doi: 10.1001/jamanetworkopen.2019.4223.

6.

Accrual to Clinical Trials (ACT): A Clinical and Translational Science Award Consortium Network.

Visweswaran S, Becich MJ, D'Itri VS, Sendro ER, MacFadden D, Anderson NR, Allen KA, Ranganathan D, Murphy SN, Morrato EH, Pincus HA, Toto R, Firestein GS, Nadler LM, Reis SE.

JAMIA Open. 2018 Oct;1(2):147-152. doi: 10.1093/jamiaopen/ooy033. Epub 2018 Aug 21.

7.

Relation of Anterior Cruciate Ligament Tears to Potential Chronic Cardiovascular diseases.

Meehan WP, Weisskopf MG, Krishnan S, McCracken C, Zafonte R, Taylor HA, Baggish A, Pascual-Leone A, Nadler LM, Speizer FE.

Am J Cardiol. 2018 Dec 1;122(11):1879-1884. doi: 10.1016/j.amjcard.2018.08.030. Epub 2018 Sep 7.

PMID:
30282598
8.

Infusion of Alloanergized Donor Lymphocytes after CD34-selected Haploidentical Myeloablative Hematopoietic Stem Cell Transplantation.

Davies JK, Brennan LL, Wingard JR, Cogle CR, Kapoor N, Shah AJ, Dey BR, Spitzer TR, de Lima M, Cooper LJ, Thall PF, Champlin RE, Nadler LM, Guinan EC.

Clin Cancer Res. 2018 Sep 1;24(17):4098-4109. doi: 10.1158/1078-0432.CCR-18-0449. Epub 2018 May 16.

9.

American-Style Football and Cardiovascular Health.

Kim JH, Zafonte R, Pascuale-Leon A, Nadler LM, Weisskopf M, Speizer FE, Taylor HA, Baggish AL.

J Am Heart Assoc. 2018 Apr 4;7(8). pii: e008620. doi: 10.1161/JAHA.118.008620. Review. No abstract available.

10.

Alloanergization of human T cells results in expansion of alloantigen-specific CD8(+) CD28(-) suppressor cells.

Barbon CM, Davies JK, Voskertchian A, Kelner RH, Brennan LL, Nadler LM, Guinan EC.

Am J Transplant. 2014 Feb;14(2):305-18. doi: 10.1111/ajt.12575. Epub 2014 Jan 10.

11.

Ex vivo alloanergization with belatacept: a strategy to selectively modulate alloresponses after transplantation.

Davies JK, Barbon CM, Voskertchian A, Nadler LM, Guinan EC.

Cell Transplant. 2012;21(9):2047-61. doi: 10.3727/096368912X637479. Epub 2012 Apr 10.

PMID:
22507909
12.

Ex vivo expansion of human CD8+ T cells using autologous CD4+ T cell help.

Butler MO, Imataki O, Yamashita Y, Tanaka M, Ansén S, Berezovskaya A, Metzler G, Milstein MI, Mooney MM, Murray AP, Mano H, Nadler LM, Hirano N.

PLoS One. 2012;7(1):e30229. doi: 10.1371/journal.pone.0030229. Epub 2012 Jan 12.

13.

IL-21 can supplement suboptimal Lck-independent MAPK activation in a STAT-3-dependent manner in human CD8(+) T cells.

Imataki O, Ansén S, Tanaka M, Butler MO, Berezovskaya A, Milstein MI, Kuzushima K, Nadler LM, Hirano N.

J Immunol. 2012 Feb 15;188(4):1609-19. doi: 10.4049/jimmunol.1003446. Epub 2012 Jan 11.

14.

Induction of HLA-DP4-restricted anti-survivin Th1 and Th2 responses using an artificial antigen-presenting cell.

Tanaka M, Butler MO, Ansén S, Imataki O, Berezovskaya A, Nadler LM, Hirano N.

Clin Cancer Res. 2011 Aug 15;17(16):5392-401. doi: 10.1158/1078-0432.CCR-10-3083. Epub 2011 Jun 24.

15.

Aberrant expression of functional BAFF-system receptors by malignant B-cell precursors impacts leukemia cell survival.

Maia S, Pelletier M, Ding J, Hsu YM, Sallan SE, Rao SP, Nadler LM, Cardoso AA.

PLoS One. 2011;6(6):e20787. doi: 10.1371/journal.pone.0020787. Epub 2011 Jun 8.

16.

Establishment of antitumor memory in humans using in vitro-educated CD8+ T cells.

Butler MO, Friedlander P, Milstein MI, Mooney MM, Metzler G, Murray AP, Tanaka M, Berezovskaya A, Imataki O, Drury L, Brennan L, Flavin M, Neuberg D, Stevenson K, Lawrence D, Hodi FS, Velazquez EF, Jaklitsch MT, Russell SE, Mihm M, Nadler LM, Hirano N.

Sci Transl Med. 2011 Apr 27;3(80):80ra34. doi: 10.1126/scitranslmed.3002207.

17.

Induction of alloantigen-specific anergy in human peripheral blood mononuclear cells by alloantigen stimulation with co-stimulatory signal blockade.

Davies JK, Barbon CM, Voskertchian AR, Nadler LM, Guinan EC.

J Vis Exp. 2011 Mar 14;(49). pii: 2673. doi: 10.3791/2673.

18.

Targeting of active mTOR inhibits primary leukemia T cells and synergizes with cytotoxic drugs and signaling inhibitors.

Batista A, Barata JT, Raderschall E, Sallan SE, Carlesso N, Nadler LM, Cardoso AA.

Exp Hematol. 2011 Apr;39(4):457-472.e3. doi: 10.1016/j.exphem.2011.01.005. Epub 2011 Jan 26.

PMID:
21277936
19.

A phase III study of anti-B4-blocked ricin as adjuvant therapy post-autologous bone marrow transplant: CALGB 9254.

Furman RR, Grossbard ML, Johnson JL, Pecora AL, Cassileth PA, Jung SH, Peterson BA, Nadler LM, Freedman A, Bayer RL, Bartlett NL, Hurd DD, Cheson BD; Cancer Leukemia Group B; Eastern Cooperative Oncology Group.

Leuk Lymphoma. 2011 Apr;52(4):587-96. doi: 10.3109/10428194.2010.543714. Epub 2011 Jan 28.

20.

A panel of human cell-based artificial APC enables the expansion of long-lived antigen-specific CD4+ T cells restricted by prevalent HLA-DR alleles.

Butler MO, Ansén S, Tanaka M, Imataki O, Berezovskaya A, Mooney MM, Metzler G, Milstein MI, Nadler LM, Hirano N.

Int Immunol. 2010 Nov;22(11):863-73. doi: 10.1093/intimm/dxq440. Epub 2010 Nov 8.

21.

Combining CD19 redirection and alloanergization to generate tumor-specific human T cells for allogeneic cell therapy of B-cell malignancies.

Davies JK, Singh H, Huls H, Yuk D, Lee DA, Kebriaei P, Champlin RE, Nadler LM, Guinan EC, Cooper LJ.

Cancer Res. 2010 May 15;70(10):3915-24. doi: 10.1158/0008-5472.CAN-09-3845. Epub 2010 Apr 27.

22.

Expansion of allospecific regulatory T cells after anergized, mismatched bone marrow transplantation.

Davies JK, Nadler LM, Guinan EC.

Sci Transl Med. 2009 Oct 7;1(1):1ra3. doi: 10.1126/scitranslmed.3000153.

23.

Cyclin D1-specific cytotoxic T lymphocytes are present in the repertoire of cancer patients: implications for cancer immunotherapy.

Kondo E, Maecker B, Weihrauch MR, Wickenhauser C, Zeng W, Nadler LM, Schultze JL, von Bergwelt-Baildon MS.

Clin Cancer Res. 2008 Oct 15;14(20):6574-9. doi: 10.1158/1078-0432.CCR-08-0825.

24.

Dissociation of its opposing immunologic effects is critical for the optimization of antitumor CD8+ T-cell responses induced by interleukin 21.

Ansén S, Butler MO, Berezovskaya A, Murray AP, Stevenson K, Nadler LM, Hirano N.

Clin Cancer Res. 2008 Oct 1;14(19):6125-36. doi: 10.1158/1078-0432.CCR-08-1146.

25.

Induction of alloanergy in human donor T cells without loss of pathogen or tumor immunity.

Davies JK, Yuk D, Nadler LM, Guinan EC.

Transplantation. 2008 Sep 27;86(6):854-64. doi: 10.1097/TP.0b013e3181861b6c. Erratum in: Transplantation. 2012 Jun 15;93(11):e44. Dosage error in article text.

26.

CpG oligodeoxynucleotides alter lymphocyte and dendritic cell trafficking in humans.

Haining WN, Davies J, Kanzler H, Drury L, Brenn T, Evans J, Angelosanto J, Rivoli S, Russell K, George S, Sims P, Neuberg D, Li X, Kutok J, Morgan J, Wen P, Demetri G, Coffman RL, Nadler LM.

Clin Cancer Res. 2008 Sep 1;14(17):5626-34. doi: 10.1158/1078-0432.CCR-08-0526.

27.

Identification of an evolutionarily conserved transcriptional signature of CD8 memory differentiation that is shared by T and B cells.

Haining WN, Ebert BL, Subrmanian A, Wherry EJ, Eichbaum Q, Evans JW, Mak R, Rivoli S, Pretz J, Angelosanto J, Smutko JS, Walker BD, Kaech SM, Ahmed R, Nadler LM, Golub TR.

J Immunol. 2008 Aug 1;181(3):1859-68.

28.

Outcome of alloanergized haploidentical bone marrow transplantation after ex vivo costimulatory blockade: results of 2 phase 1 studies.

Davies JK, Gribben JG, Brennan LL, Yuk D, Nadler LM, Guinan EC.

Blood. 2008 Sep 15;112(6):2232-41. doi: 10.1182/blood-2008-03-143636. Epub 2008 Jul 10.

29.

Interleukin-4 stimulates proliferation and growth of T-cell acute lymphoblastic leukemia cells by activating mTOR signaling.

Cardoso BA, Martins LR, Santos CI, Nadler LM, Boussiotis VA, Cardoso AA, Barata JT.

Leukemia. 2009 Jan;23(1):206-8. doi: 10.1038/leu.2008.178. Epub 2008 Jul 3. No abstract available.

30.

Lee Marshall Nadler, MD: a conversation with the editor.

Nadler LM, Roberts WC.

Proc (Bayl Univ Med Cent). 2007 Oct;20(4):381-9. No abstract available.

31.

Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission.

Brown JR, Feng Y, Gribben JG, Neuberg D, Fisher DC, Mauch P, Nadler LM, Freedman AS.

Biol Blood Marrow Transplant. 2007 Sep;13(9):1057-65. Epub 2007 Jul 16.

32.

Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cell.

Butler MO, Lee JS, Ansén S, Neuberg D, Hodi FS, Murray AP, Drury L, Berezovskaya A, Mulligan RC, Nadler LM, Hirano N.

Clin Cancer Res. 2007 Mar 15;13(6):1857-67.

33.

Identification of an immunogenic CD8+ T-cell epitope derived from gamma-globin, a putative tumor-associated antigen for juvenile myelomonocytic leukemia.

Hirano N, Butler MO, Xia Z, Berezovskaya A, Murray AP, Ansén S, Kojima S, Nadler LM.

Blood. 2006 Oct 15;108(8):2662-8. Epub 2006 Jun 15.

34.

Efficient presentation of naturally processed HLA class I peptides by artificial antigen-presenting cells for the generation of effective antitumor responses.

Hirano N, Butler MO, Xia Z, Berezovskaya A, Murray AP, Ansén S, Nadler LM.

Clin Cancer Res. 2006 May 15;12(10):2967-75.

35.

Rapid, reliable and inexpensive quality assessment of biotinylated cRNA.

Zander T, Yunes JA, Cardoso AA, Nadler LM.

Braz J Med Biol Res. 2006 May;39(5):589-93. Epub 2006 Apr 20.

36.

Leukemia-stimulated bone marrow endothelium promotes leukemia cell survival.

Veiga JP, Costa LF, Sallan SE, Nadler LM, Cardoso AA.

Exp Hematol. 2006 May;34(5):610-21.

PMID:
16647567
37.

CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvants.

von Bergwelt-Baildon M, Shimabukuro-Vornhagen A, Popov A, Klein-Gonzalez N, Fiore F, Debey S, Draube A, Maecker B, Menezes I, Nadler LM, Schultze JL.

Blood. 2006 Apr 1;107(7):2786-9. Epub 2005 Dec 15.

38.

Gene expression profiling identifies BAX-delta as a novel tumor antigen in acute lymphoblastic leukemia.

Maia S, Haining WN, Ansén S, Xia Z, Armstrong SA, Seth NP, Ghia P, den Boer ML, Pieters R, Sallan SE, Nadler LM, Cardoso AA.

Cancer Res. 2005 Nov 1;65(21):10050-8.

39.

Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity.

Hirano N, Butler MO, Xia Z, Ansén S, von Bergwelt-Baildon MS, Neuberg D, Freeman GJ, Nadler LM.

Blood. 2006 Feb 15;107(4):1528-36. Epub 2005 Oct 20.

40.

Proangiogenic stimulation of bone marrow endothelium engages mTOR and is inhibited by simultaneous blockade of mTOR and NF-kappaB.

Costa LF, Balcells M, Edelman ER, Nadler LM, Cardoso AA.

Blood. 2006 Jan 1;107(1):285-92. Epub 2005 Sep 1.

41.

Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia.

Gribben JG, Zahrieh D, Stephans K, Bartlett-Pandite L, Alyea EP, Fisher DC, Freedman AS, Mauch P, Schlossman R, Sequist LV, Soiffer RJ, Marshall B, Neuberg D, Ritz J, Nadler LM.

Blood. 2005 Dec 15;106(13):4389-96. Epub 2005 Aug 30.

42.

Phase I/II combined chemoimmunotherapy with carcinoembryonic antigen-derived HLA-A2-restricted CAP-1 peptide and irinotecan, 5-fluorouracil, and leucovorin in patients with primary metastatic colorectal cancer.

Weihrauch MR, Ansén S, Jurkiewicz E, Geisen C, Xia Z, Anderson KS, Gracien E, Schmidt M, Wittig B, Diehl V, Wolf J, Bohlen H, Nadler LM.

Clin Cancer Res. 2005 Aug 15;11(16):5993-6001.

43.

Rare naturally occurring immune responses to three epitopes from the widely expressed tumour antigens hTERT and CYP1B1 in multiple myeloma patients.

Maecker B, von Bergwelt-Baildon MS, Anderson KS, Vonderheide RH, Anderson KC, Nadler LM, Schultze JL.

Clin Exp Immunol. 2005 Sep;141(3):558-62.

44.

Unexpected association between induction of immunity to the universal tumor antigen CYP1B1 and response to next therapy.

Gribben JG, Ryan DP, Boyajian R, Urban RG, Hedley ML, Beach K, Nealon P, Matulonis U, Campos S, Gilligan TD, Richardson PG, Marshall B, Neuberg D, Nadler LM.

Clin Cancer Res. 2005 Jun 15;11(12):4430-6.

45.

Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemia.

Haining WN, Neuberg DS, Keczkemethy HL, Evans JW, Rivoli S, Gelman R, Rosenblatt HM, Shearer WT, Guenaga J, Douek DC, Silverman LB, Sallan SE, Guinan EC, Nadler LM.

Blood. 2005 Sep 1;106(5):1749-54. Epub 2005 May 26.

46.

Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma.

Brown JR, Yeckes H, Friedberg JW, Neuberg D, Kim H, Nadler LM, Freedman AS.

J Clin Oncol. 2005 Apr 1;23(10):2208-14. Epub 2005 Mar 7.

PMID:
15753460
47.

Failure to define window of time for autologous tumor vaccination in patients with newly diagnosed or relapsed acute lymphoblastic leukemia.

Haining WN, Cardoso AA, Keczkemethy HL, Fleming M, Neuberg D, DeAngelo DJ, Stone RM, Galinsky I, Silverman LB, Sallan SE, Nadler LM, Guinan EC.

Exp Hematol. 2005 Mar;33(3):286-94.

PMID:
15730852
48.

Identification of a new HLA-A*0201-restricted cryptic epitope from CYP1B1.

Maecker B, von Bergwelt-Baildon MS, Sherr DH, Nadler LM, Schultze JL.

Int J Cancer. 2005 Jun 10;115(2):333-6.

49.

Presence of anti-kinectin and anti-PMS1 antibodies in Japanese aplastic anaemia patients.

Hirano N, Butler MO, Guinan EC, Nadler LM, Kojima S.

Br J Haematol. 2005 Jan;128(2):221-3.

PMID:
15638857
50.

Common gamma chain-signaling cytokines promote proliferation of T-cell acute lymphoblastic leukemia.

Barata JT, Keenan TD, Silva A, Nadler LM, Boussiotis VA, Cardoso AA.

Haematologica. 2004 Dec;89(12):1459-67.

Supplemental Content

Loading ...
Support Center